GS1 India organised its Healthcare Conference, “The Next Frontier in Healthcare: Standardised, Sustainable & Safe”, on 9th October 2026 at the India Habitat Centre, New Delhi. As regulatory expectations rise and the sector digitises at pace, the conference focused on how shared standards and cross-industry partnerships can make healthcare safer, transparent and more connected. The day featured keynote addresses, panel discussions, presentations and case studies by senior leaders from across the sector.
A common thread across the sessions was the need for a single, reliable identity for every healthcare product. Speakers explored how globally accepted GS1 standards, interoperable 2D barcodes and Unique Device Identification can strengthen authentication, improve recall management and reduce the risk of falsified products. Discussions also looked ahead at the role of registries and trusted data in India’s digital health journey, the responsible adoption of artificial intelligence (AI) in patient care, and the importance of aligning Indian regulations with international requirements.
Joint Drug Controller of India, CDSCO
Associate Secretary General, Indian Pharmaceutical Alliance
Partner Healthcare, KPMG India
CCO & Country Head, Transasia Bio-Medicals Ltd
Director, Boehringer Ingelheim
Director, National Health Authority
Co-Founder and Director, Kanvic Consulting
Head Supply Chain, Roche Pharma
Director - Regulatory Affairs, Philips India
Director Regulatory Affairs, Eli Lilly & Company
Senior Manager Quality & Digital Transformation, Indian Immunologicals Ltd.
Partner Healthcare, Deloitte
Director, Regulatory Affairs & Government Affairs, Becton Dickinson
Head Regulatory Affairs South Asia, Bayer Pharmaceuticals
Commercial Manager Q&R IMEA & Asia, Roche
CEO, Developing Countries Vaccine Manufacturers Network
Head - Regulatory Affairs & Training, Appasamy Associates
General Manager - Global Packaging Development & Device Development, Alkem Laboratories
Senior Manager, Business Process, Gilead Sciences
Health Policy Specialist , NITI Aayog
Head Pharmacologist, Apollo Hospitals
Assistant Vice President, Biological E
COO, Pharmarack
Vice President, TATA 1mg
Director, J & J
Senior Manager, Public Policy Healthcare
Consultant Gastroenterologist, and Motivational speaker, Kailash Healthcare Ltd.
The audience included delegates from regulatory and government agencies, pharmaceutical and medical device manufacturers, hospitals, e-pharmacies, distribution platforms and advisory firms. Many of the speakers drew on their own implementation journeys, offering delegates a realistic view of what it takes to adopt standards at scale. Beyond the formal sessions, the event gave participants the chance to connect with peers throughout the healthcare value chain and build relationships for future collaboration.
At the GS1 India Healthcare Conference 2026, themed “The Next Frontier...
The conversation explored how India’s digital health ecosystem is bein...
Speakers noted that measures such as tamper-evident packaging and 2D b...
Panellists identified the point at which a product leaves the manufact...
The panel opened with a session address by Dr. Sonali Rawal, NITI Aayo...
